Clinical Trial Update: Long Term Prediction of MASH-related HCC Risk by Proteomics

View source ↗

Summary

A University Hospital, Bordeaux-sponsored study is examining long-term prediction of hepatocellular carcinoma risk in metabolic-associated steatohepatitis (MASH…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Metabolic-associated Steatohepatitis

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: MASH-related HCC | Status: NOT_YET_RECRUITING